Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study

BACKGROUND: Integument-related toxicities are common during epidermal growth factor receptor (EGFR)-targeted therapy. Panitumumab is a fully human monoclonal antibody targeting the EGFR that significantly improves progression-free survival when added to chemotherapy in patients with metastatic color...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Thaler, Josef, Karthaus, Meinolf, Mineur, Laurent, Greil, Richard, Letocha, Henry, Hofheinz, Ralf, Fernebro, Eva, Gamelin, Erick, Baños, Ana, Köhne, Claus-Henning
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3520865/
https://ncbi.nlm.nih.gov/pubmed/23020584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-438
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky